Oragenics, Inc. (OGEN)
0.4767
-0.04
(-8.15%)
USD |
NYAM |
Sep 18, 16:00
0.4951
+0.02
(+3.86%)
After-Hours: 20:00
Oragenics Price to Book Value : 0.586 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.586 |
| September 17, 2026 | 0.638 |
| September 16, 2026 | 0.6146 |
| September 15, 2026 | 0.5994 |
| September 14, 2026 | 0.6134 |
| September 11, 2026 | 0.5876 |
| September 10, 2026 | 0.6187 |
| September 09, 2026 | 0.6331 |
| September 08, 2026 | 0.642 |
| September 04, 2026 | 0.6269 |
| September 03, 2026 | 0.6128 |
| September 02, 2026 | 0.6221 |
| September 01, 2026 | 0.6134 |
| August 31, 2026 | 0.6267 |
| August 28, 2026 | 0.6444 |
| August 27, 2026 | 0.6539 |
| August 26, 2026 | 0.6515 |
| August 25, 2026 | 0.6393 |
| August 24, 2026 | 0.6386 |
| August 21, 2026 | 0.6453 |
| August 20, 2026 | 0.6638 |
| August 19, 2026 | 0.6517 |
| August 18, 2026 | 0.6712 |
| August 17, 2026 | 0.6576 |
| August 14, 2026 | 0.6551 |
| Date | Value |
|---|---|
| August 13, 2026 | 0.6516 |
| August 12, 2026 | 0.6592 |
| August 11, 2026 | 0.6747 |
| August 10, 2026 | 0.6736 |
| August 07, 2026 | 0.676 |
| August 06, 2026 | 0.6681 |
| August 05, 2026 | 0.6638 |
| August 04, 2026 | 0.6761 |
| August 03, 2026 | 0.6506 |
| July 31, 2026 | 0.6146 |
| July 30, 2026 | 0.6026 |
| July 29, 2026 | 0.6106 |
| July 28, 2026 | 0.6109 |
| July 27, 2026 | 0.6158 |
| July 24, 2026 | 0.6281 |
| July 23, 2026 | 0.6209 |
| July 22, 2026 | 0.6515 |
| July 21, 2026 | 0.6638 |
| July 20, 2026 | 0.6651 |
| July 17, 2026 | 0.6756 |
| July 16, 2026 | 0.6857 |
| July 15, 2026 | 0.6884 |
| July 14, 2026 | 0.6955 |
| July 13, 2026 | 0.7007 |
| July 10, 2026 | 0.7204 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.534 |
Price to Book Value Related Metrics
| Price | 0.4767 |
| Earnings Yield | -751.6% |
| Market Cap | 2.151M |